News

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...
A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is ...
Data suggest that OSA diagnoses were associated with an increased risk for physical and psychological problems in active-duty ...
Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...
RingConn, a leading smart ring innovator, has officially launched its flagship Gen 2 Smart Ring and accessories on ...
This can lead to delays in diagnosis as sleep apnea in women can be mistaken for anxiety, depression and menopause. As the ...
Apnimed, Inc., a pharmaceutical company advancing an industry-leading pipeline of first-in-class oral therapies that address the root causes of obstructive sleep apnea (OSA) and other sleep-related ...
Alzheimer's disease affects more than 6 million Americans, and emerging research identifies Obstructive Sleep Apnea (OSA) as a significant, modifiable risk factor. Interrupted breathing during sleep c ...
Most associate sleep apnea with snoring, but it’s the sound of silence doctors say patients should be concerned with.
A new study found active-duty service members with sleep apnea face a greater risk of PTSD or a traumatic brain injury, ...
The sleep apnea detection feature that Apple's most recent Apple Watch models offer has expanded to several more countries in ...
Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative ...